SCHEMBL17899158

SCHEMBL17899158

CC(=O)c1ccc(C(N)=O)c(Nc2ccc(OCCOC3CCOCC3)cc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 5/20 0.41
AKR1C2 P52895 5/20 0.41
SIRT2 Q8IXJ6 2/20 0.39
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
SPIN1 Q9Y657 1/20 0.37
TBK1 Q9UHD2 2/20 0.37
F10 P00742 1/20 0.36
PRSS1 P07477 1/20 0.36
PRSS2 P07478 1/20 0.36
F7 P08709 1/20 0.36
F3 P13726 1/20 0.36
PRSS3 P35030 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
SYK P43405 2/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17888600 0.93 AKR1C3 (0.39) AKR1C3AKR1C2SIRT2KDM4EALDH1A1
SCHEMBL17931447 0.88 MAPT (0.40) AKR1C3AKR1C2SIRT2KDM4EALDH1A1
SCHEMBL17888635 0.88 AKR1C3 (0.41) AKR1C3AKR1C2SIRT2KDM4EALDH1A1
SCHEMBL17899152 0.87 AKR1C3 (0.38) AKR1C3AKR1C2SPIN1TBK1F10
SCHEMBL23190672 0.85 SPIN1 (0.38) AKR1C3AKR1C2SIRT2SPIN1TBK1
SCHEMBL17899379 0.84 RAB9A (0.38) AKR1C3AKR1C2KDM4EALDH1A1SPIN1
SCHEMBL17888611 0.84 ALDH1A1 (0.43) KDM4EALDH1A1TBK1
SCHEMBL17899405 0.83 KDM4E (0.40) KDM4EALDH1A1TBK1L3MBTL1GAA
SCHEMBL17888618 0.83 AKR1C3 (0.45) AKR1C3AKR1C2KDM4EALDH1A1SPIN1
SCHEMBL17888646 0.82 TBK1 (0.38) SIRT2TBK1F10PRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11013728-B2 Cyclin-dependent kinase 8 and/or 19 inhibitor KYOTO PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2021-05-25 US disclosed
US-20210100783-A1 NOVEL CYCLIN-DEPENDENT KINASE 8 AND/OR 19 INHIBITOR KYOTO PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2021-04-08 US disclosed
EP-3607944-A1 NOVEL CYCLIN-DEPENDENT KINASE 8 AND/OR 19 INHIBITOR Kyoto Pharmaceutical Industries, Ltd. (JP) 2020-02-12 EP disclosed
US-20160207883-A1 NOVEL AROMATIC COMPOUND AND USE THEREOF KYOTO PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2016-07-21 US disclosed
US-20160207883-A1 NOVEL AROMATIC COMPOUND AND USE THEREOF KYOTO PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2016-07-21 US disclosed
EP-3040329-A1 NOVEL AROMATIC COMPOUND AND USE THEREOF Kyoto Pharmaceutical Industries, Ltd. (JP) 2016-07-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160207883-A1 NOVEL AROMATIC COMPOUND AND USE THEREOF SOST, BMP2, ALPI AKR1C3 721/4885AKR1C2 1087/4885SIRT2 1773/4885
US-20210100783-A1 NOVEL CYCLIN-DEPENDENT KINASE 8 AND/OR 19 INHIBITOR CCNI, CDK9, CDK8 AKR1C3 2658/4885AKR1C2 2210/4885SIRT2 1579/4885
US-11013728-B2 Cyclin-dependent kinase 8 and/or 19 inhibitor CCNI, CDK9, CDKN1A AKR1C3 2920/4885AKR1C2 2502/4885SIRT2 1496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.